Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Dwight, M. M.
* Articles by Keck, P. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Dwight, M. M.
* Articles by Keck, P. E., Jr.
Related Collections
* Depression
Psychosomatics 39:14-17, February 1998
© 1998 The Academy of Psychosomatic Medine

An Open Clinical Trial of Venlafaxine Treatment of Fibromyalgia

Megan M. Dwight, M.D., Lesley M. Arnold, M.D., Hadley O'Brien, M.S.H.P.A., Ray Metzger, B.S., Emily Morris-Park, B.A., and Paul E. Keck, Jr., M.D.

Received September 17, 1996; revised December 4, 1996; accepted February 6, 1997. From the Division of Psychosomatic Research, Biological Psychiatry Program, Department of Psychiatry, University of Cincinnati, Ohio. Address reprint requests to Dr. Arnold, P.O. Box 670559, University of Cincinnati College of Medicine, Cincinnati, OH 45267.

Of 15 patients with fibromyalgia who were first evaluated for the presence of Axis I psychiatric diagnoses by use of the Structured Clinical Interview for DSM-IV, 11 completed an open 8-week trial with the novel antidepressant venlafaxine. Six (55%) of 11 completers experienced a >=50% reduction of fibromyalgia symptoms. The presence of lifetime psychiatric disorders, particularly depressive and anxiety disorders, predicted a positive response to venlafaxine. These findings suggest that it is important to assess for comorbid psychiatric disorders in patients with fibromyalgia and that venlafaxine may be helpful to some of these patients.

Key Words: Venlafaxine • Fibromyalgia • Antidepressant




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
S. Perrot, R.-M. Javier, M. Marty, C. Le Jeunne, F. Laroche, and the CEDR (Cercle d'Etude de la Douleur en Rhumatol
Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies
Rheumatology, August 1, 2008; 47(8): 1117 - 1123.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
H. V. Krell, A. F. Leuchter, I. A. Cook, and M. Abrams
Evaluation of Reboxetine, a Noradrenergic Antidepressant, for the Treatment of Fibromyalgia and Chronic Low Back Pain
Psychosomatics, October 1, 2005; 46(5): 379 - 384.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. L. Goldenberg, C. Burckhardt, and L. Crofford
Management of Fibromyalgia Syndrome
JAMA, November 17, 2004; 292(19): 2388 - 2395.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
T. Muller, M. Mannel, H. Murck, and V. W. Rahlfs
Treatment of Somatoform Disorders With St. John's Wort: A Randomized, Double-Blind and Placebo-Controlled Trial
Psychosom Med, July 1, 2004; 66(4): 538 - 547.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
K. Sayar, G. Aksu, I. Ak, and M. Tosun
Venlafaxine Treatment of Fibromyalgia
Ann. Pharmacother., November 1, 2003; 37(11): 1561 - 1565.
[Abstract] [Full Text] [PDF]


Home page
Acad. PsychiatryHome page
R. J. Leo, C. A. Pristach, and J. Streltzer
Incorporating Pain Management Training Into the Psychiatry Residency Curriculum
Acad Psychiatry, March 1, 2003; 27(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. I. Hudson, B. Mangweth, H. G. Pope Jr, C. De Col, A. Hausmann, S. Gutweniger, N. M. Laird, W. Biebl, and M. T. Tsuang
Family Study of Affective Spectrum Disorder
Arch Gen Psychiatry, February 1, 2003; 60(2): 170 - 177.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
A. H. Clayton and J. Kaltsounis-Puckett
Combination Therapy in the Treatment of Major Depressive Disorder Complicated by Fibromyalgia and Menopause
Psychosomatics, December 1, 2002; 43(6): 491 - 493.
[Full Text] [PDF]


Home page
PsychosomaticsHome page
L. M. Arnold, P. E. Keck Jr., and J. A. Welge
Antidepressant Treatment of Fibromyalgia: A Meta-Analysis and Review
Psychosomatics, April 1, 2000; 41(2): 104 - 113.
[Abstract] [Full Text]


Home page
Rheumatology (Oxford)Home page
S. RICHARDS and A. CLEARE
Treating fibromyalgia
Rheumatology, April 1, 2000; 39(4): 343 - 346.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. J. Leventhal
Management of Fibromyalgia
Ann Intern Med, December 7, 1999; 131(11): 850 - 858.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
S. A. Epstein, G. Kay, D. Clauw, R. Heaton, D. Klein, L. Krupp, J. Kuck, V. Leslie, D. Masur, M. Wagner, et al.
Psychiatric Disorders in Patients With Fibromyalgia: A Multicenter Investigation
Psychosomatics, February 1, 1999; 40(1): 57 - 63.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1998 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org